Advertisement
|
| 13 Health - Multiple Sclerosis (MS) Resources |
| Acorda Shares Up As MS Drug Ampyra Shows Early Strength In 2Q |
| Acorda Therapeutics Inc. reported strong sales in its first full quarter of selling the multiple sclerosis symptoms treatment Ampyra, sending its shares 6.3% higher in midday trading. |
| View Source | August 3, 2010 | Provides Information |
| B |
| Bone-marrow stem cells in MS show promise |
| A groundbreaking trial to test bone marrow stem cell therapy with a small group of patients with multiple sclerosis (MS) has been shown to have possible benefits for the treatment of the disease. |
| View Source | May 5, 2010 | Provides Information |
| C |
| Can multiple sclerosis attacks be minimized in a war zone? |
| Multiple sclerosis patients who directly confronted the stress of the Second Lebanon War suffered fewer attacks than those who chose to cope with the situation by focusing on feelings. This has been shown in a new study carried out by researchers of the University of Haifa, the Technion-Israel Institute of Technology and Carmel Medical Center. "Because there is no cure for multiple sclerosis to date, it is important to uncover all the factors that impact the recurrence of attacks," said Prof. Eli Somer of the University of Haifa, one of the authors of the study. |
| View Source | June 21, 2010 | Provides Information |
| Clinical utility and pharmacological action of MN-166 in treatment of MS |
| MediciNova, Inc, a biopharmaceutical company publicly traded on the Nasdaq Global Market and the Hercules Market of the Osaka Securities Exchange, today reported that this week's issue of Neurology includes two articles related to the potential clinical utility and unique pharmacological action of MN-166 in treating multiple sclerosis (MS). |
| View Source | April 3, 2010 | Provides Information |
| D |
| Does smoking compound other MS risk factors? |
| A new study shows that smoking may increase the risk of multiple sclerosis (MS) in people who also have specific established risk factors for MS. |
| View Source | April 7, 2010 | Provides Information |
| J |
| J.K. Rowling gives $15.4 million to MS research |
| ‘Harry Potter’ author’s mom died of complications related to disease |
| View Source | August 31, 2010 | Provides Information |
| L |
| Lack of Sleep Triggers 'Migraine' Proteins |
| New Research Helps Explain Why Sleep Deprivation Triggers Migraines, Other Chronic Pain Conditions |
| View Source | June 24, 2010 | Provides Information |
| Low Vitamin D Levels Are Related to MS Brain Atrophy, Cognitive Function, Studies Show |
| Low vitamin D levels may be associated with more advanced physical disability and cognitive impairment in persons with multiple sclerosis, studies conducted by neurologists at the University at Buffalo have shown. |
| View Source | April 28, 2010 | Provides Information |
| M |
| MS study suggests key role of environmental factor in the disease |
| Scientists are reporting what they say is compelling evidence that some powerful non-heritable, environmental factor likely plays a key role in the development of multiple sclerosis. |
| View Source | April 28, 2010 | Provides Information |
| N |
| New study shows utility of Chronix Biomedical's serum DNA tests in MS |
| New study published in Journal of Molecular Diagnostics follows recent publication showing utility of Chronix's serum DNA tests in breast cancer |
| View Source | April 6, 2010 | Provides Information |
| O |
| Of bugs and brains: Researchers discover that gut bacteria affect multiple sclerosis |
| Biologists at the California Institute of Technology have demonstrated a connection between multiple sclerosis (MS) -- an autoimmune disorder that affects the brain and spinal cord -- and gut bacteria. |
| View Source | July 19, 2010 | Provides Information |
| R |
| Researchers explore new ways to reverse the damage caused by multiple sclerosis and other neurological disorders |
| A National Institutes of Health grant will help University of Central Florida researchers explore new ways to potentially reverse the damage caused by multiple sclerosis and other neurological disorders. |
| View Source | May 10, 2010 | Provides Information |
| U |
| USF receives patent for technology to improve treatment for neurodegenerative diseases |
| The University of South Florida's Department of Neurosurgery and Brain Repair has been granted a patent for a cell transplantation procedure combining human umbilical cord blood (HUCB) cells and a sugar-alcohol compound called "mannitol" that may make a big difference in treating life-threatening neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, multiple sclerosis and stroke, among others. |
| View Source | July 8, 2010 | Provides Information |